Latent TB Testing Market Set to Reach USD 1,005.69 Million by 2034, Registering a CAGR of 5.7%

Latent TB Testing Market Analysis: Opportunities, Innovations, and Growth Potential Through 2025-2034

The global Latent TB Testing Market was valued at USD 576.68 million in 2024, and it is projected to grow to USD 1,005.69 million by 2034. During the forecast period from 2025-2034, the market is estimated to rise at a compound annual growth rate (CAGR) of 5.7%.

Market Definition

The Latent Tuberculosis (TB) Testing Market comprises diagnostic tools and services used to detect latent TB infections—where individuals are infected with Mycobacterium tuberculosis but show no active symptoms. Common tests include the Tuberculin Skin Test (TST) and Interferon-Gamma Release Assays (IGRAs), which assess the immune response to the bacteria. These tests are critical for high-risk populations such as healthcare workers, immunocompromised patients, and individuals in regions with high TB prevalence. Early detection helps prevent progression to active TB and reduce transmission. Governments and healthcare organizations across the globe are increasingly prioritizing TB control programs, driving adoption of latent TB diagnostics.

Key Report Highlights  

  • The report highlights the key region that accounts for the highest revenue share in the global Latent TB Testing market.
  • It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.
  • The report outlines the dominant segment that holds a major share of the market.
  • It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.
  • Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.

Market Overview: Key Figures at a Glance

  • Market Value in 2024: USD 576.68 million
  • Projected Market Size in 2034: USD 1,005.69 million
  • Anticipated CAGR (2025-2034):5.7%

Get access to the full report or request a complimentary sample for in-depth analysis:

https://www.polarismarketresearch.com/industry-analysis/latent-tb-testing-market/request-for-sample 

Market Growth Drivers: Latent TB Testing Market

  • Rising global TB burden, especially in developing countries.

  • Growing public health initiatives for TB screening and control.

  • Increasing adoption of IGRAs for more accurate diagnosis.

  • Expanding awareness and testing among high-risk populations.

  • Support from WHO and government policies for TB eradication.

Market Key Players

The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include

  • Abbott Laboratories
  • AID Autoimmun Diagnostika GmbH 
  • ARKRAY, Inc. 
  • Beijing Wantai Biopharmaceutical Co., Ltd. 
  • bioMérieux 
  • Boditech Med Inc. 
  • Endo, Inc. 
  • Lionex GmbH 
  • Oxford Immunotec (PerkinElmer) 
  • QIAGEN           
  • Revvity 
  • Sanofi 
  • SD Biosensor, INC. 
  • Serum Institute of India Pvt. Ltd. 
  • Zhi Fei Biological 

Similar Posts